Targeting the Ubiquitin E3 Ligase MuRF1 to Inhibit Muscle Atrophy

Overview of attention for article published in Cell Biochemistry and Biophysics, March 2011

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (72nd percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

patent: 3 patents

Citations

dimensions_citation: 45 Dimensions

Readers on

mendeley: 80 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

LIGASE E3 RNF185 INHIBITORS AND USES THEREOF

Application WO-2015018831-A1

World Intellectual Property Organisation (WIPO)

Ligase E3 RNF185 inhibitors and uses thereof

Application EP-2835423-A1

European Patent Office

AMIDOXIME DERIVATIVES FOR THE PREVENTION AND/OR TREATMENT OF MUSCLE ATROPHY

Application WO-2013024311-A1

World Intellectual Property Organisation (WIPO)